Drug Type Small molecule drug |
Synonyms ASC45F |
Target |
Mechanism FAS modulators(Fatty acid synthase modulators), THR-β agonists(Thyroid hormone receptor beta-1 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Gannex Pharma Co Ltd.Startup |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
MASH | Preclinical | US | Gannex Pharma Co Ltd.Startup | 30 Jan 2022 |